Abbott’s Navitor Aortic Heart Valve Replacement Scores European Approval 2021-05-17T20:58:51-04:00May 17th, 2021| share this article! Abbott Laboratories’ (NYSE: ABT) Navitor transcatheter aortic valve implantation (TAVI) system has received a CE mark, making it available in Europe to those… Read More share this article! Related Posts Worst-ever interviews: ‘They told us to crawl and moo’ May 3rd, 2024 Have the wheels come off for Tesla? May 3rd, 2024 Is Palantir An Attractive AI Stock Buy Ahead Of Earnings May 3rd, 2024 Court Unanimously Overturns Farhy, Finding IRS Has Authority To Assess Penalties May 3rd, 2024
